These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15821632)

  • 21. [Acid suppression capacity of omeprazole, sodium bicarbonate and alginic acid in an oral powder combination].
    Soifer L; Peralta AD; Arenoso H; Caruso N; Naisberg G
    Acta Gastroenterol Latinoam; 2009 Dec; 39(4):261-6. PubMed ID: 20178255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: a prospective randomized comparative trial.
    Lin HJ; Lo WC; Cheng YC; Perng CL
    Am J Gastroenterol; 2006 Mar; 101(3):500-5. PubMed ID: 16542286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical implications of immediate-release PPI therapy in the management of GERD and upper GI bleeding. Introduction.
    Peura DA
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():1. PubMed ID: 16303030
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.
    Gasiorowska A; Navarro-Rodriguez T; Wendel C; Krupinski E; Perry ZH; Koenig K; Moty B; Powers J; Fass R
    Am J Gastroenterol; 2009 Aug; 104(8):2005-13. PubMed ID: 19491829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intragastric pH with oral vs intravenous bolus plus infusion proton-pump inhibitor therapy in patients with bleeding ulcers.
    Laine L; Shah A; Bemanian S
    Gastroenterology; 2008 Jun; 134(7):1836-41. PubMed ID: 18423628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada.
    Rahme E; Barkun A; Nedjar H; Gaugris S; Watson D
    Am J Gastroenterol; 2008 Apr; 103(4):872-82. PubMed ID: 18371130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid.
    Chuong MC; Taglieri CA; Kerr SG
    Int J Pharm Compd; 2017; 21(6):500-512. PubMed ID: 29220339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review article: the role of antisecretory therapy in the management of non-variceal upper gastrointestinal bleeding.
    Triadafilopoulos G
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():53-8. PubMed ID: 16303038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of gastric banding on pharmacotherapy: not much known].
    Wilting I; van den Bemt PM; Brenninkmeijer SJ; Spooren PF; Siemons AA; Egberts AC
    Ned Tijdschr Geneeskd; 2007 May; 151(20):1112-5. PubMed ID: 17557666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spectrophotometric and chromatographic determination of omeprazole in pharmaceutical formulations.
    Gallardo V; López-Viota M; Sierra J; Ruiz MA
    Pharm Dev Technol; 2009; 14(5):516-23. PubMed ID: 19267285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors influencing the shift of patients from one proton pump inhibitor to another: the effect of direct-to-consumer advertising.
    Hansen RA; Shaheen NJ; Schommer JC
    Clin Ther; 2005 Sep; 27(9):1478-87. PubMed ID: 16291421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of proton pump inhibitor cotherapy in patients taking long-term, low-dose aspirin for secondary cardiovascular prevention.
    Saini SD; Schoenfeld P; Fendrick AM; Scheiman J
    Arch Intern Med; 2008 Aug; 168(15):1684-90; discussion 1691. PubMed ID: 18695083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.
    Gilard M; Arnaud B; Cornily JC; Le Gal G; Lacut K; Le Calvez G; Mansourati J; Mottier D; Abgrall JF; Boschat J
    J Am Coll Cardiol; 2008 Jan; 51(3):256-60. PubMed ID: 18206732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of use of proton pump inhibitors in Greece.
    Ntaios G; Chatzinikolaou A; Kaiafa G; Savopoulos C; Hatzitolios A; Karamitsos D
    Eur J Intern Med; 2009 Mar; 20(2):171-3. PubMed ID: 19327607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colon-specific delivery tablets of sodium 4-aminosalicylic acid.
    Li Y; Li HJ; Yang GR; Gu WP; Ma YK; Zhang MH; Sun J; Sun SJ
    Yao Xue Xue Bao; 2006 Oct; 41(10):927-32. PubMed ID: 17184108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In brief: Mucinex.
    Med Lett Drugs Ther; 2005 Feb; 47(1202):16. PubMed ID: 15711500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yosprala - a combination of aspirin and omeprazole.
    Med Lett Drugs Ther; 2017 Jan; 59(1513):25-26. PubMed ID: 28118652
    [No Abstract]   [Full Text] [Related]  

  • 38. One on one. I often have heartburn. Is it safe to use Prilosec OTC long term?
    Mayo Clin Womens Healthsource; 2004 Aug; 8(8):8. PubMed ID: 15311184
    [No Abstract]   [Full Text] [Related]  

  • 39. Omeprazole 20 mg equal to 40 mg for primary care acid-related dyspepsia.
    J Fam Pract; 2004 Nov; 53(11):873. PubMed ID: 15527722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immediate-Release Omeprazole/Sodium Bicarbonate.
    Howden CW
    Gastroenterol Hepatol (N Y); 2006 May; 2(5):386. PubMed ID: 28289345
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.